Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102782064 | 10278206 | 4 | F | 2013 | 20160713 | 20140704 | 20160718 | EXP | CA-ROCHE-1409566 | ROCHE | 0.00 | F | Y | 0.00000 | 20160718 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102782064 | 10278206 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LAST DOSE: 03/JAN/2014. | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
| 102782064 | 10278206 | 2 | SS | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | U | 0 | 50 | MG | ||||||||
| 102782064 | 10278206 | 3 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
| 102782064 | 10278206 | 4 | C | HUMIRA | ADALIMUMAB | 1 | Unknown | PRE-RITUXAN | 0 | ||||||||||
| 102782064 | 10278206 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 102782064 | 10278206 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 102782064 | 10278206 | 7 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 102782064 | 10278206 | 8 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 102782064 | 10278206 | 9 | C | LYSINE | LYSINE | 1 | 0 | ||||||||||||
| 102782064 | 10278206 | 10 | C | PROLIA | DENOSUMAB | 1 | 0 | ||||||||||||
| 102782064 | 10278206 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102782064 | 10278206 | 1 | Rheumatoid arthritis |
| 102782064 | 10278206 | 2 | Premedication |
| 102782064 | 10278206 | 3 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102782064 | 10278206 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102782064 | 10278206 | Eczema | |
| 102782064 | 10278206 | Iritis | |
| 102782064 | 10278206 | Osteoporosis | |
| 102782064 | 10278206 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102782064 | 10278206 | 1 | 20120510 | 0 | ||
| 102782064 | 10278206 | 2 | 20120510 | 0 | ||
| 102782064 | 10278206 | 3 | 20120510 | 0 | ||
| 102782064 | 10278206 | 11 | 20120510 | 0 |